VECT
Price:
$16.87
Market Cap:
$1.06B
VectivBio Holding AG, a clinical stage biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines for treatments of severe rare conditions. It develops apraglutide, a long-acting synthetic peptide analog of glucagon-like peptide-2 that is in Phase III clinical trial for the treatment of patients with short bowel syndrome-intestinal failure (SBS-IF), as well as apraglutide is in Phase II clinical trial for SBS-IF in patients with colon-in-continuity anatomy. The company is also developing apraglutide, which is in Phase II clinical trial for patients with steroid-refractory gastrointestinal acute versus host disease (aGvHD). The company was incorporate...[Read more]
Industry
Biotechnology
IPO Date
2021-04-08
Stock Exchange
NASDAQ
Ticker
VECT
According to VectivBio Holding AG’s latest financial reports and current stock price. The company's current PE Ratio is -8.03. This represents a change of 558.77% compared to the average of -1.22 of the last 4 quarters.
The mean historical PE Ratio of VectivBio Holding AG over the last ten years is -5.03. The current -8.03 PE Ratio has changed 15.86% with respect to the historical average. Over the past ten years (40 quarters), VECT's PE Ratio was at its highest in in the March 2018 quarter at 0. The PE Ratio was at its lowest in in the March 2019 quarter at -16.87.
Average
-5.03
Median
-2.70
Minimum
-16.87
Maximum
0
Discovering the peaks and valleys of VectivBio Holding AG PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 168.15%
Maximum Annual PE Ratio = 0
Minimum Annual Increase = -Infinity%
Minimum Annual PE Ratio = -16.87
Year | PE Ratio | Change |
---|---|---|
2022 | -4.08 | 168.15% |
2021 | -1.52 | -43.61% |
2020 | -2.70 | -84.01% |
2019 | -16.87 | -Infinity% |
The current PE Ratio of VectivBio Holding AG (VECT) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
-2.77
5-year avg
-5.03
10-year avg
-5.03
VectivBio Holding AG’s PE Ratio is less than CNS Pharmaceuticals, Inc. (-0.00), less than ZyVersa Therapeutics, Inc. (-0.10), less than eFFECTOR Therapeutics, Inc. (-0.00), less than AVROBIO, Inc. (2.07), less than Immix Biopharma, Inc. (-2.98), less than Hepion Pharmaceuticals, Inc. (-0.15), less than CohBar, Inc. (-0.20), less than Ocean Biomedical, Inc. (-0.17), less than Enveric Biosciences, Inc. (-0.36), less than Elevation Oncology, Inc. (-0.93), greater than Zura Bio Limited (-9.00),
Company | PE Ratio | Market cap |
---|---|---|
-0.00 | $4.60M | |
-0.10 | $2.70M | |
-0.00 | $188.18K | |
2.07 | $5.24M | |
-2.98 | $54.08M | |
-0.15 | $4.20M | |
-0.20 | $1.25M | |
-0.17 | $33.96M | |
-0.36 | $4.53M | |
-0.93 | $36.94M | |
-9.00 | $230.86M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like VectivBio Holding AG using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like VectivBio Holding AG or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is VectivBio Holding AG's PE Ratio?
How is the PE Ratio calculated for VectivBio Holding AG (VECT)?
What is the highest PE Ratio for VectivBio Holding AG (VECT)?
What is the 3-year average PE Ratio for VectivBio Holding AG (VECT)?
What is the 5-year average PE Ratio for VectivBio Holding AG (VECT)?
How does the current PE Ratio for VectivBio Holding AG (VECT) compare to its historical average?